Amgen (AMGN) Receives FDA Approval for BLINCYTO sBLA in Ph- r/r ALL
Go back to Amgen (AMGN) Receives FDA Approval for BLINCYTO sBLA in Ph- r/r ALLAmgen Inc (NASDAQ: AMGN) | Delayed: 268.93 +6.18 (2.35%) | |||||
---|---|---|---|---|---|---|
Previous Close | $262.75 | 52 Week High | $176.85 | |||
Open | $264.63 | 52 Week Low | $133.64 | |||
Day High | $269.38 | P/E | 40.50 | |||
Day Low | $260.68 | EPS | $6.64 | |||
Volume | 3,380,076 |